Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 1 de 1
Filtre
Ajouter des filtres








Gamme d'année
1.
Clinics ; 67(supl.1): 19-28, 2012. ilus, tab
Article Dans Anglais | LILACS | ID: lil-623126

Résumé

Head and neck paragangliomas are tumors arising from specialized neural crest cells. Prominent locations are the carotid body along with the vagal, jugular, and tympanic glomus. Head and neck paragangliomas are slowly growing tumors, with some carotid body tumors being reported to exist for many years as a painless lateral mass on the neck. Symptoms depend on the specific locations. In contrast to paraganglial tumors of the adrenals, abdomen and thorax, head and neck paragangliomas seldom release catecholamines and are hence rarely vasoactive. Petrous bone, jugular, and tympanic head and neck paragangliomas may cause hearing loss. The internationally accepted clinical classifications for carotid body tumors are based on the Shamblin Class I-III stages, which correspond to postoperative permanent side effects. For petrous-bone paragangliomas in the head and neck, the Fisch classification is used. Regarding the molecular genetics, head and neck paragangliomas have been associated with nine susceptibility genes: NF1, RET, VHL, SDHA, SDHB, SDHC, SDHD, SDHAF2 (SDH5), and TMEM127. Hereditary HNPs are mostly caused by mutations of the SDHD gene, but SDHB and SDHC mutations are not uncommon in such patients. Head and neck paragangliomas are rarely associated with mutations of VHL, RET, or NF1. The research on SDHA, SDHAF2 and TMEM127 is ongoing. Multiple head and neck paragangliomas are common in patients with SDHD mutations, while malignant head and neck paraganglioma is mostly seen in patients with SDHB mutations. The treatment of choice is surgical resection. Good postoperative results can be expected in carotid body tumors of Shamblin Class I and II, whereas operations on other carotid body tumors and other head and neck paragangliomas frequently result in deficits of the cranial nerves adjacent to the tumors. Slow growth and the tendency of hereditary head and neck paragangliomas to be multifocal may justify less aggressive treatment strategies.


Sujets)
Humains , Tumeurs de la tête et du cou/génétique , Tumeurs de la tête et du cou/anatomopathologie , Paragangliome/génétique , Paragangliome/anatomopathologie , Tumeur du glomus carotidien/classification , Tumeur du glomus carotidien/génétique , Tumeur du glomus carotidien/anatomopathologie , Tumeur du glomus carotidien/chirurgie , Gènes tumoraux , Prédisposition génétique à une maladie/génétique , Tumeurs de la tête et du cou/chirurgie , Stadification tumorale , Paragangliome/chirurgie , Tumeurs de la base du crâne/anatomopathologie , Tumeurs de la base du crâne/chirurgie
SÉLECTION CITATIONS
Détails de la recherche